[1]
“Hubungan Kuantitatif Struktur-Aktivitas dan Desain Senyawa Novel PhenylBenzimidazoles sebagai Penghambat Wnt/β-Catenin untuk Terapi PancreaticDuctal Adenocarcinoma: Quantitative Structure-Activity Relationship and Design of Novel PhenylBenzimidazoles as Wnt/β-Catenin Inhibitors for Pancreatic DuctalAdenocarcinoma Therapy”, J. Sains. Kes, vol. 5, no. 5, pp. 584–590, Nov. 2024, doi: 10.30872/jsk.v5i5.438.